Supplement × Prescription·Evidence index
PubMed indexes 7 records that name Calcium and Ibandronate together, either in the title or in an interaction, co-administration, or pharmacokinetic context. The key findings come first, in the authors’ own words, followed by every study with its design and PubMed link.
A summary of published research, not medical advice. A pharmacist can check any combination against your full list of medicines and supplements.
Reviews and human studies first. Each quote is the authors’ own conclusion about their study, not a NutriStack assessment, and a single study is not a consensus.
“This validated K-PD model is currently being used to evaluate a range of novel intermittent oral and i.v. ibandronate regimens in an ongoing clinical development programme.”
“Additional sodium fluoride or ibandronate had no benefit over calcium and cholecalciferol alone in managing reduced BMD in CD.”
“ibandronate injections effectively reduce bone turnover and increase BMD in Japanese women with osteoporosis. Ibandronate injections provide a new option for the treatment of osteoporosis.”
Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.
“Additional sodium fluoride or ibandronate had no benefit over calcium and cholecalciferol alone in managing reduced BMD in CD.”
Names both Calcium and Ibandronate in its title.
Names both Calcium and Ibandronate in its title.
Names both Calcium and Ibandronate in its title.
“ibandronate injections effectively reduce bone turnover and increase BMD in Japanese women with osteoporosis. Ibandronate injections provide a new option for the treatment of osteoporosis.”
Names both Calcium and Ibandronate in its title.
“This validated K-PD model is currently being used to evaluate a range of novel intermittent oral and i.v. ibandronate regimens in an ongoing clinical development programme.”
Names Calcium and Ibandronate together in an interaction, co-administration, or pharmacokinetic context.
“Thus the efficacy of etidronate as treatment for soft tissue calcification brought with it a problematic tendency to cause osteomalacia. In contrast, conventional doses of nitrogen-containing bisphosphonates fail to yield circulating concentrations sufficient to exert direct anti-calcifying effects, at least in patients with good renal function and studies using alendronate and ibandronate have yielded inconsistent vascular outcomes.”
Names Calcium and Ibandronate together in an interaction, co-administration, or pharmacokinetic context.
“Calcitriol dosage increased from 1.5 to 1.83 microg/week. In patients with renal osteodystrophy and ESRD, ibandronate significantly increased BMD and decreased bone turnover.”
Names Calcium and Ibandronate together in an interaction, co-administration, or pharmacokinetic context.
Search-based evidence indexes have real limits, and it is worth being explicit about them:
NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Calcium, Ibandronate, and several hundred other substances.
Log your routine, get reminders at the times you choose, and scan a label to add a product. The checker is a research and organisation tool, not a clinical decision aid.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
